MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuroprotective and neurotrophic efficacy of Ginkgo biloba extracts against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

P. Kashyap, S. Gupta (Darbhanga, India)

Meeting: 2019 International Congress

Abstract Number: 23

Keywords: Acetylcholine, Aging, Cognitive dysfunction

Session Information

Date: Monday, September 23, 2019

Session Title: Huntington’s Disease

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: The present study examined the potential neuroprotective and neurotrophic efficacy of GBE against 3-nitropropionic acid (3-NP)-induced oxidative stress in a rat model of HD and explored the mechanisms of action.

Background: Huntington’s disease (HD) is a progressive neurodegenerative disorder. Ginkgo biloba extracts (GBE), a phytoestrogen, has been widely used for treating coronary heart disease and neurological disease in clinical settings and demonstrated beneficial effects at biochemical and pharmacological levels.

Method: 60 Male SD  rats were pretreated with GBE (25 and 50 mg/kg b.w.) orally prior to the intraperitoneally (i.p.) administration of 3-NP (12 mg/kg b.w.) for 15 days. Nimodipine (12 mg/kg, po)  was used as positive control drugs. The body weight , grip strength and behavior were monitored within  5th, 10th and 15th day after 3-NP treatment. Then the animals were sacrificed, neuronal damage in striatum was estimated using Nissl staining. Hsp70 expression was detected with immunohistochemistry. Reactive oxygen species (ROS) generation was measured using dihydroethidium (DHE) staining. Memory (Morris water maze) , antioxidants enzymes, acetylcholinesterase (AChE) activity, cycloxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression  were analyzed in rat model of HD .

Results: Present results shown that administration of 3-NP resulted in a marked reduction in the body weight, memory, grip strength  locomotion activity and significantly increased oxidative stress, AChE activity, COX-2 and inducible iNOS expression. GBE   (25 and 50 mg/kg) treated animals exhibited a significant improvement in behavioural, biochemical, histological alterations and oxidative stress parameters in comparison to only 3-NP treated animals. Present results shown dose-dependently improved 3-NP-induced behavioral, biochemical, and enzymatic changes.  Similar effects were obtained with the positive control drugs nimodipine.

Conclusion: This study suggests neuroprotective, neurotrophic and memory enhancing effects for GBE in a rat model of HD. These effects might be attributed to its antiaging, antioxidant and anti-inflammatory activities.

To cite this abstract in AMA style:

P. Kashyap, S. Gupta. Neuroprotective and neurotrophic efficacy of Ginkgo biloba extracts against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/neuroprotective-and-neurotrophic-efficacy-of-ginkgo-biloba-extracts-against-3-nitropropionic-acid-induced-oxidative-stress-in-a-rat-model-of-huntingtons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuroprotective-and-neurotrophic-efficacy-of-ginkgo-biloba-extracts-against-3-nitropropionic-acid-induced-oxidative-stress-in-a-rat-model-of-huntingtons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley